Compare Agilent Technologies Inc (A) vs Bank of America Corp (BAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Bank of America Corp — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Bank of America Corp trades at $64.02 (market cap $446.56B). The key difference: Bank of America Corp is far larger — about 10.6× Agilent Technologies Inc's market cap, and Bank of America Corp pays the higher dividend (2%). Which is the better fit depends on your goals.
| A | BAC | |
|---|---|---|
Market Cap | $42.00B | $446.56B |
Sector | Health | Financials |
52-Week High | $157.20 | $63.86 |
52-Week Low | $110.24 | $46.16 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | 2% |
Volume | — | 55,637,172 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Bank of America (BAC) trades at $63.17, up 0.27% today, with strong technical momentum indicated by bullish moving averages. The company demonstrates solid fundamental performance with Q2 2026 EPS beating expectations at $1.21 versus $1.13, marking the third consecutive quarterly beat. Revenue growth accelerated to $113.1 billion in 2025, with net income reaching $30.51 billion. Recent developments include strategic partnerships with FIFA and continued investment in talent acquisition.
BAC presents a compelling investment case with analyst consensus strongly favoring buy ratings (64.82%) and a $67.36 price target offering 6.6% upside. The bank's massive deposit franchise and improving net interest margins support earnings growth. Key risks include sensitivity to interest rate changes and potential regulatory changes from upcoming stress tests. The stock's current valuation at 14.59 P/E appears reasonable given earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Bank of America Corp
Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.
Read more on BAC →
